Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ZYUS Life Sciences Corp V.PCO


Primary Symbol: V.ZYUS Alternate Symbol(s):  ZLSCF

Healthcare
ZYUS Life Sciences Corporation is a Canada-based life sciences company. The Company is focused on the global development and commercialization of cannabinoid-based pharmaceutical drug product candidates and exempt market therapeutics. Through clinical research, it is committed to furthering the understanding of cannabinoids with the clinical development of its pharmaceutical drug product candidates and intellectual property activities to protect its novel formulations. Additionally, the Company delivers cGMP / EU GMP-compliant cannabinoid products to patients through the exempt global medical market. The Company is also focused on commercialization of its exempt market therapeutics, such as cannabinoid oils, soft gel capsules and topical creams, in Canada and those international markets where medical cannabis is legal.


TSXV:ZYUS - Post by User

ZYUS Life Sciences Corp
Bullboard Posts
User Avatar Image
(0)
•••
Post by Schwarzetulpeon Oct 27, 2006 1:57pm
540 Views
Post# 11568909

News

News The trading halt was generated as a result of news from yesterday, the 26th of October, 2006. It is in regards to the granting of a US patent on Phoenix Oil's hydrogen gas generation technology. The news report can be found at: https://new.stockwatch.com/swnet/newsit/newsit_newsit.aspx?bid=B-612098-C:PCO&symbol=PCO&news_region=C If there is anyone from the company who may come upon this blog post I would ask that they post this latest news on this website as well as globeinvestor.com. A little bit of exposure will do the company some good as it's efforts are worthwhile to reward.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities